Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular TreatmentMacarena Hernández‐Jiménez, Marc Ribó, María Hernández‐Pérez et al.|JAMA Neurology|2023Cited by 80
Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trialMikaël Mazighi, Mathieu Zuber, Martin Köhrmann et al.|The Lancet Neurology|2024Cited by 64
Inhibidores de la proproteína convertasa subtilisina/kexina tipo 9 (iPCSK9) en la prevención secundaria de episodios vasculares en pacientes con ictus isquémico: Documento de consenso y aplicaciones prácticasAntonio Gil-Núñez, E. Palacio, Jaime Masjuán et al.|Neurología|2021Cited by 3
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidanceAntonio Gil-Núñez, E. Palacio, Jaime Masjuán et al.|Neurología (English Edition)|2021Cited by 3